Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 116, pseudogene (RNU6-116P) is a member of a family of pseudogenes derived from the U6 small nuclear RNA (snRNA) locus. U6 snRNA is a non-coding RNA and an essential part of the spliceosomal machinery responsible for intron excision from pre-mRNA in eukaryotes, but pseudogene copies such as RNU6-116P do not contribute functional RNA and do not participate in splicing[3][2][1]. These pseudogene loci are common in vertebrate genomes and are considered the result of retrotranspositional events, for instance via LINE-1 elements, marking genomic sites of historical retrotransposition[1][4]. While they do not have catalytic or regulatory activity themselves, they provide insights into genome evolution and retrotransposon dynamics, and sometimes are studied for their role as molecular fossils of splicing-related RNA[4]. There are no diseases specifically associated with RNU6-116P, nor are there drugs or biomarkers that target or use this pseudogene. If you are seeking structured information for drug discovery or biotherapeutic targeting, RNU6-116P is not a suitable target because it is a non-functional pseudogene and does not encode a molecule with biological activity, binding site, or signaling property. For the functional relevance, primary research would focus on the parent gene (U6 snRNA) and its core biological roles rather than the pseudogene copy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 116, pseudogene (RNU6-116P).